VET3-TGI

· KaliVir Immunotherapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VET3-TGI, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of VET3-TGI in Patients With Solid Tumors [Phase 1]